Study Finds MicroRNA Signatures for Blood-Based Lung Cancer Test
May 19, 2011
Study Finds MicroRNA Signatures for Blood-Based Lung Cancer Test
A study published earlier this spring by OSU researchers identified a set of miRNA signatures in blood that could yield a new test for lung cancer development and prognosis.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Chicago Team Finds miRNAs Convert Fibroblasts around Ovarian Tumors to Promote Cancer
November 29, 2012 / Gene Silencing News - Abcodia, VolitionRx Collaborate on Nucleosome-based Dx for Cancer
February 17, 2012 / GenomeWeb Daily News - Pathway Analysis Approach IDs miR-548d as Potential Superior Regulator in Pancreatic Cancer
October 6, 2011 / Gene Silencing News - BU to Lead $3.3M Cancer Dx Studies
December 17, 2010 / GenomeWeb Daily News - Inherited Risk Mutation for Lung Cancer? Researchers Launch INHERIT EGFR Registry to Investigate
May 15, 2013 / Pharmacogenomics Reporter